Cowen & Co. analyst Andrew Charles maintains Wingstop (NASDAQ:WING) with a Outperform and raises the price target from $180 to $200.
HC Wainwright & Co. Reiterates Buy on Aldeyra Therapeutics, Maintains $15 Price Target
HC Wainwright & Co. analyst Matthew Caufield reiterates Aldeyra Therapeutics (NASDAQ:ALDX) with a Buy and maintains $15 price target.